US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ブラジル
BOV
Cemepe Invests Sa (MAPT3) 銘柄情報

Cemepe Invests Sa (MAPT3)

2.50

0.00

(0.00%)

終了 7月11日 5:55AM

Cemepe Invests Sa (MAPT3) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

2.50

( - )

買値

0.00

売値

0.00

出来高

-

平均取引量 (3 か月)

R$ 133

財務取引量

-

0.00 日の範囲 0.00

2.50 52 週間の範囲 3.01

時価総額

企業価値

2.529M

前日終値

2.50

始値

-

時刻

最終取引時間

VWAP

-

歳入

-

純利益

-104k

発行済株式数

918,895

浮動株比率 (%)

7.86%

機関投資家保有比率 (%)

-

配当利回り

PER

-26.51

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-0.11

ベータ

-0.5

Cemepe Investimentos S.A., through its subsidiaries, manages its own and third-party resources in Brazil. It also provides technical, financial, and administrative consultancy services. The company was formerly known as Companhia Marcopolo de Participações and changed its name to Cemepe Investimento... Cemepe Investimentos S.A., through its subsidiaries, manages its own and third-party resources in Brazil. It also provides technical, financial, and administrative consultancy services. The company was formerly known as Companhia Marcopolo de Participações and changed its name to Cemepe Investimentos S.A. in April 1993. Cemepe Investimentos S.A. was incorporated in 1991 and is based in Rio De Janeiro, Brazil. Cemepe Investimentos S.A. operates as a subsidiary of Cemisa Participações Ltda. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.cemepe.com.br

本社

Rio De Janeiro, Brazil

設立

1991

Cemepe Invests Sa is listed in the sector of the ボベスパ (ブラジル) with ticker MAPT3. The last closing price for CEMPE ON was R$2.50. Over the last year, CEMPE ON shares have traded in a share price range of R$ 2.50 to R$ 3.01.

CEMPE ON currently has 918,895 shares in issue. The market capitalisation of CEMPE ON is R$2.30 million. CEMPE ON has a price to earnings ratio (PE ratio) of -26.51.

(MAPT3) - ATENCAO PARA O CALL - PRECO R$ 5,50

(MAPT3) - ATENCAO PARA O CALL - PRECO R$ 5,50

(MAPT3) - ATENCAO PARA O CALL - PRECO R$ 13,00

(MAPT3) - ATENCAO PARA O CALL - PRECO R$ 13,00

(MAPT3) - ATENCAO PARA O CALL - PRECO R$ 13,00

(MAPT3) - ATENCAO PARA O CALL - PRECO R$ 13,00

(MAPT3) - ATENCAO:NOVO PRECO-BASE PARA O LIMITE ESTATICO - R$ 7,14

(MAPT3) - ATENCAO:NOVO PRECO-BASE PARA O LIMITE ESTATICO - R$ 7,14

(MAPT3) - ATENCAO:NOVO PRECO-BASE PARA O LIMITE ESTATICO - R$ 6.96

(MAPT3) - ATENCAO:NOVO PRECO-BASE PARA O LIMITE ESTATICO - R$ 6.96

(MAPT3) - ATENCAO:NOVO PRECO-BASE PARA O LIMITE ESTATICO - R$ 6,86

(MAPT3) - ATENCAO:NOVO PRECO-BASE PARA O LIMITE ESTATICO - R$ 6,86

(MAPT3) - ATENCAO PARA O CALL - PRECO R$ 6,00

(MAPT3) - ATENCAO PARA O CALL - PRECO R$ 6,00

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	-0.02	-0.793650793651	2.52	2.55	2.5	500	2.508	CS
26	-0.5	-16.6666666667	3	3	2.5	325	2.62153846	CS
52	-0.51	-16.9435215947	3.01	3.01	2.5	275	2.77681818	CS
156	-25.9	-91.1971830986	28.4	38	2.5	820	7.22024096	CS
260	-35	-93.3333333333	37.5	38	2.5	789	7.49171386	CS

MAPT3 - Frequently Asked Questions (FAQ)

What is the current Cemepe Invests Sa share price?

The current share price of Cemepe Invests Sa is R$ 2.50

How many Cemepe Invests Sa shares are in issue?

Cemepe Invests Sa has 918,895 shares in issue

What is the market cap of Cemepe Invests Sa?

The market capitalisation of Cemepe Invests Sa is BRL 2.3M

What is the 1 year trading range for Cemepe Invests Sa share price?

Cemepe Invests Sa has traded in the range of R$ 2.50 to R$ 3.01 during the past year

What is the PE ratio of Cemepe Invests Sa?

The price to earnings ratio of Cemepe Invests Sa is -26.51

What is the registered address of Cemepe Invests Sa?

The registered address for Cemepe Invests Sa is Tiradentes Square, 10 - Room 304, Rio De Janeiro, Rio de Janeiro, 20060-070

What is the Cemepe Invests Sa website address?

The website address for Cemepe Invests Sa is www.cemepe.com.br

Which industry sector does Cemepe Invests Sa operate in?

Cemepe Invests Sa operates in the Financeiro e Outros sector

shajandr

shajandr 4分前

Dave:

Prison - you're nott gonna like big boy prison.

https://investorshub.advfn.com/uimage/uploads/2026/7/11/exmlgbeaumont.jpg
https://investorshub.advfn.com/uimage/uploads/2014/3/21/m[igcinmateArrival.jpg
https://investorshub.advfn.com/uimage/uploads/202

chereb19

chereb19 14分前

Every time you're wrong, you don't revisit your thesis—you just invent a new one. First it was "they'll never get an IDE." Then it became "it's only an EFS IDE." Now it's dilution, patents and OTC. The conclusion never changes; only the excuse does.

You're throwing everything at the w

Kool Aid Man

Kool Aid Man 18分前

Q:--"Why would a Royal Qatari Sheikh worth multi-millions need an infamous, maxed out, toxic ticker littered with legal landmines in order to 'self fund' mining and drilling on at least 3 continents then split his profits with decades of old HIRU bag holders???"

A: He doesn't

shajandr

shajandr 21分前

Roofie the prison janitor.

jjjjjjjj

jjjjjjjj 28分前

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3
IT IS DAMNED IF IT GOES UP, DAMNED IF IT GOES DOWN!
Which is it??? I repeat: IT IS DAMNED IF IT GOES UP. DAMNED IF IT GOES DOWN! Is today Mond

Kool Aid Man

Kool Aid Man 29分前

Has the bank said "no money was lost"? Then why are they suing?

rosemountbomber

rosemountbomber 49分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 51分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 1時間前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 1時間前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 1時間前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 1時間前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 1時間前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 1時間前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Genz2 1時間前

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 2時間前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 2時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Horace Mann Educators

DB X-Trackers S&P 500 2x...

Societe Generale Societe...

American Leisure (EM)

Equity Trustees

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。